Literature DB >> 18218674

Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis.

M Manco1, G Bedogni, M Marcellini, R Devito, P Ciampalini, M R Sartorelli, D Comparcola, F Piemonte, V Nobili.   

Abstract

OBJECTIVE: Waist circumference is widely accepted as a risk factor for cardiovascular disease and metabolic syndrome. Non-alcoholic fatty liver disease (NAFLD) is a feature of the metabolic syndrome. A contribution of metabolic syndrome, and especially of waist circumference, to liver fibrosis in children with NAFLD is strongly suspected.
DESIGN: Cross-sectional study.
SETTING: Department of Hepatogastroenterology and Nutrition, Paediatric Hospital "Bambino Gesù", Rome, Italy. PATIENTS: 197 consecutive Caucasian children with NAFLD (136 males and 61 females) aged 3-19 years. MAIN OUTCOME MEASURES: Multivariable logistic regression models were used to examine the contribution of gender, age, body mass index (BMI) and metabolic syndrome components (waist circumference, high-density lipoprotein (HDL)-cholesterol, triglycerides, blood pressure and glucose) to the odds of liver fibrosis as detected by liver biopsy.
RESULTS: 92% of the children had BMI > or = 85(th) percentile and 84% had a waist > or = 90(th) percentile for gender and age. Ten per cent of the children had metabolic syndrome and 67% had liver fibrosis, mostly of low degree. At multivariable analysis, waist was the only metabolic syndrome component to be associated with liver fibrosis. This was seen both when the components of the metabolic syndrome were coded as dichotomous (odds ratio (OR) = 2.40; 95% confidence interval (CI), 1.04 to 5.54) and continuous (OR = 2.07; 95% CI, 1.43 to 2.98 for a 5 cm increase). In the latter case, age was also associated with the outcome (OR = 0.70; 95% CI, 0.55 to 0.89 for a 1 year increase).
CONCLUSIONS: Abdominal rather than generalised obesity contributes to liver fibrosis in children with NAFLD. Waist is also the only component of the metabolic syndrome to be associated with fibrosis in these children. Therefore, the presence of abdominal obesity is an additional criterion for the selection of children and adolescents who should undergo extensive investigation, including liver biopsy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18218674     DOI: 10.1136/gut.2007.142919

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  40 in total

Review 1.  Fatty liver disease in children--what should one do?

Authors:  Kristin S Bramlage; Vivek Bansal; Stavra A Xanthakos; Rohit Kohli
Journal:  Indian J Pediatr       Date:  2012-06-22       Impact factor: 1.967

Review 2.  Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.

Authors:  Emer Fitzpatrick; Anil Dhawan
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

3.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

Authors:  Miriam B Vos; Stephanie H Abrams; Sarah E Barlow; Sonia Caprio; Stephen R Daniels; Rohit Kohli; Marialena Mouzaki; Pushpa Sathya; Jeffrey B Schwimmer; Shikha S Sundaram; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

Review 4.  Update on fatty liver disease and steatohepatitis.

Authors:  Fatima Zahra Aly; David E Kleiner
Journal:  Adv Anat Pathol       Date:  2011-07       Impact factor: 3.875

Review 5.  Developmental programming of pediatric nonalcoholic fatty liver disease: redefining the"first hit".

Authors:  Michael S Stewart; Margaret J R Heerwagen; Jacob E Friedman
Journal:  Clin Obstet Gynecol       Date:  2013-09       Impact factor: 2.190

Review 6.  Nonalcoholic fatty liver disease: current issues and novel treatment approaches.

Authors:  Romina Lomonaco; Nishanth E Sunny; Fernando Bril; Kenneth Cusi
Journal:  Drugs       Date:  2013-01       Impact factor: 9.546

Review 7.  The metabolic syndrome and nonalcoholic fatty liver disease in children.

Authors:  Shikha S Sundaram; Phil Zeitler; Kristen Nadeau
Journal:  Curr Opin Pediatr       Date:  2009-08       Impact factor: 2.856

8.  Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh.

Authors:  Shahinul Alam; Sheikh Mohammad Noor-E-Alam; Ziaur Rahman Chowdhury; Mahabubul Alam; Jahangir Kabir
Journal:  World J Hepatol       Date:  2013-05-27

9.  Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery.

Authors:  Perrie E Pardee; Joel E Lavine; Jeffrey B Schwimmer
Journal:  Semin Pediatr Surg       Date:  2009-08       Impact factor: 2.754

Review 10.  Persistent hypertransaminasemia in asymptomatic children: a stepwise approach.

Authors:  Pietro Vajro; Sergio Maddaluno; Claudio Veropalumbo
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.